SpaceX’s next big growth engine isn’t rockets — it’s this play on AI power, analysts say
The company has a lucrative opportunity in letting rivals tap its data centers for computing power.
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
The company has a lucrative opportunity in letting rivals tap its data centers for computing power.
The chip maker is buying the startup and adding AI pioneer Fei-Fei Li as its chief scientist.
Instinct is rapidly amassing investment dollars, illustrating the rush of excitement around personal AI assistants.
Wall Street was hoping last week’s bond rout was the worst of it. Monday indicated otherwise.
The health-data company could see a pop in its stock price, but there are plenty of warning signs
Although October historically has been the most volatile month of the year, you shouldn’t bet that it will continue to be in the future.
TD Cowen analysts flagged the company’s “shifting narrative on affordability” as a risk.
It’s important to have guardrails around your legacy.
“My sister always chooses places where it’s cheapest for her to fly.”
There were no major breakthroughs on big issues including AI, Iran and Taiwan.
Almost half of the stocks in the S&P 500 have a negative beta, evidence of a chasm between the entire index and its individual components.
Micron is no longer the company it was before the AI boom, and one analyst says it’s time that investors fully appreciate that.
Nvidia’s stock has gotten cheaper even as the company has sustained robust levels of growth.
“When my paycheck lands, it takes a detour through bitcoin.”
Meta is creating an enterprise platform business that aims to make it easier for developers to use its products. CJ Desai, formerly of MongoDB, will head up the initiative.
Jim Paulsen thinks lagged indicators suggest the usual ‘best buying season’ for stocks may not be applicable this time and backtesting his model to 1970 shows meagre returns.
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
The company is getting closer to making the rocket fully reusable.
Not since the dot-com bubble have stocks thrown up this concerning metric.
The company intends to repurchase a large amount of shares through January 2028, reflecting “confidence in the long-term opportunity ahead.”
News text belongs to its source; only the headline and a short summary appear here.